byetta 10 exenatide 10 micrograms/40 microlitres (2.4ml in total) solution for injection multidose cartridge
astrazeneca pty ltd - exenatide, quantity: 250 microgram/ml - injection, solution - excipient ingredients: sodium acetate; water for injections; metacresol; glacial acetic acid; mannitol - exenatide is indicated as adjunctive therapy to improve glycaemic control in patients with type 2 diabetes mellitus who are taking metformin, a sulfonylurea, or a combination of metformin and a sulfonylurea, or a combination of metformin and a basal insulin, but are not achieving adequate glycaemic control.
byetta 5 exenatide 5 micrograms/20 microlitres (1.2ml in total) solution for injection multidose cartridge
astrazeneca pty ltd - exenatide, quantity: 250 microgram/ml - injection, solution - excipient ingredients: sodium acetate; metacresol; glacial acetic acid; mannitol; water for injections - exenatide is indicated as adjunctive therapy to improve glycaemic control in patients with type 2 diabetes mellitus who are taking metformin, a sulfonylurea, or a combination of metformin and a sulfonylurea, or a combination of metformin and a basal insulin, but are not achieving adequate glycaemic control.
exenatide 250 mcg/ml (5mcg/dose) solution for injection (sc)
astrazeneca pharmaceuticals (phils.), inc. - byetta® - solution for injection (sc) - 250 mcg/ml (5mcg/dose)
byetta 5mcg solution for injection
astrazeneca singapore pte ltd - exenatide - injection, solution - 250mcg
byetta 10micrograms0.04ml solution for injection 2.4ml pre-filled pen
astrazeneca uk ltd - exenatide - solution for injection - 250microgram/1ml
byetta 5micrograms0.02ml solution for injection 1.2ml pre-filled pen
astrazeneca uk ltd - exenatide - solution for injection - 250microgram/1ml
byetta solution
astrazeneca canada inc - exenatide - solution - 5mcg - exenatide 5mcg - incretin mimetics
byetta 10
astrazeneca limited - exenatide 250 µg/ml; - solution for injection - 10µg/40µl - active: exenatide 250 µg/ml excipient: glacial acetic acid mannitol metacresol sodium acetate trihydrate water for injection - adjunctive therapy to improve glycaemic control in patients with type 2 diabetes mellitus who are taking metformin, a sulfonylurea, or a combination of metformin and a sulfonylurea but are not achieving adequate glycaemic control. to improve glycaemic control in patients with type 2 diabetes mellitus in combination with a basal insulin with or without metformin and/or a thiozolidinedione.
byetta 5
astrazeneca limited - exenatide 250 µg/ml; - solution for injection - 5µg/20µl - active: exenatide 250 µg/ml excipient: glacial acetic acid mannitol metacresol sodium acetate trihydrate water for injection - adjunctive therapy to improve glycaemic control in patients with type 2 diabetes mellitus who are taking metformin, a sulfonylurea, or a combination of metformin and a sulfonylurea but are not achieving adequate glycaemic control. to improve glycaemic control in patients with type 2 diabetes mellitus in combination with a basal insulin with or without metformin and/or a thiozolidinedione.
exenatide 250 mcg/ml (10 mcg/dose) solution for injection (sc)
astrazeneca pharmaceuticals (phils.), inc. - byetta® - solution for injection (sc) - 250 mcg/ml (10 mcg/dose)